Clinical Trials Browser

Uveal Melanoma × belinostat × 90 days × Clear all

NCT05170334 2026-04-06

Binimetinib Plus Belinostat for Subjects With Metastatic Uveal Melanoma

Phase 2 Active not recruiting

Uveal Melanoma, Eye Neoplasms